Deficiency of the interleukin-1 receptor antagonist

DBCOND0008480Congenital, Hereditary, and Neonatal Diseases and Abnormalities Immune System Diseases

Deficiency of the interleukin-1 receptor antagonist is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Classified under: Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Immune System Diseases
Musculoskeletal and Connective Tissue Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Anakinra
Rilonacept

Resolves to

Vocabularies

ICD-10M04.8SNOMED CT773702002MedDRA10072224UMLSC2748507

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Deficiency of the interleukin-1 receptor antagonist share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account